{"retracted":false,"update":{"timestamp":1331078400000,"doi":"10.1245/s10434-012-2228-3","type":"correction"},"doi":"10.1245/s10434-011-2190-5","journal":"Annals of Surgical Oncology","publisher":"Springer Nature","title":"Erratum to: Phase II Trial of Neoadjuvant/adjuvant Imatinib Mesylate for Advanced Primary and Metastatic/recurrent Operable Gastrointestinal Stromal Tumors: Long-term Follow-up Results of Radiation Therapy Oncology Group 0132"}
